Growth in Antidepressant Prescriptions a $10B Paradox
In the study, Mojtabai and his co-author, Columbia University psychiatrist Mark Olfson, suggest that the new provider arrangements such as accountable care organizations will encourage more care coordination between primary care physicians and specialists, including psychologists and psychiatrists. That could help get antidepressant use back in line with clinical efficacy.
The study also makes two chief recommendations to help reduce the frequency of the prescribing of anti-depressants without a psychiatric diagnosis:
- Improve provider education on how to recognize mental disorders, the treatment limits of antidepressants and the long-term effects.
- Change drug formularies for antidepressants by creating cost-sharing tiers linked to diagnoses. Cost sharing would be less for patients who are prescribed the medications for recognized clinical conditions.
Mojtabai, who has studied the use of antidepressants for several years, says any policies should also look at how to make sure the drugs get to the people who really need them. "That's the paradox I've seen. Prescribing has increased but the people who really need antidepressants aren't getting them."
Margaret Dick Tocknell is a reporter/editor with HealthLeaders Media.
- MU Compliance Announcement Sparks Concern, Confusion
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- Telehealth Improves Patient Care in ICUs
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- Scary Financial Challenges for 2014
- States Rejecting Medicaid Expansion Forgo Billions in Federal Funds
- Douglas Hawthorne—A Chance to Do Something Big
- LifePoint Bolsters Presence in Michigan's Upper Peninsula
- Hospital M&A Volume Up, Value Down in 3Q
- Small Doesn't Mean Doomed